NCT04233879 · Interventional trial
Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)
Overall registry status Completed
Phase 3
Conditions HIV-1 Infection
Delaware Valley sites
- University of Pennsylvania ( Site 5630) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory